Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer
2015 · Journal of Hematology & Oncology · 56 citations
https://doi.org/10.1186/s13045-015-0164-y
C
Chengjun Feng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
159
Citations
7
h-index
5
i10-index
Chengjun Feng is an academic researcher from Nanjing University of Science and Technology. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Endometrial and Cervical Cancer Treatments & Bone health and treatments. The author has an h-index of 7, co-authored 18 publications.
Papers by this author
worksCorrelation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang
2020 · BMC Gastroenterology · 11 citations
https://doi.org/10.1186/s12876-020-01227-w
Reexamined mass of $$^{22}$$C via the constraint from the recently experimental extraction of its radius
2026 · Nuclear Science and Techniques · 0 citations
https://doi.org/10.1007/s41365-026-01904-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat